Specialists’ Symposium: Neoadjuvant Treatment in 2025

Melanoma Institute Australia invites you to join our multidisciplinary experts for our hybrid symposium as we ensure the latest evidence translates into practice - and practice into better patient outcomes.

Following recent PBS listings of neoadjuvant regimens for Stage III melanoma, there is an urgent need for practical, real-world guidance on how to implement these therapies effectively within multidisciplinary care.

Join Melanoma Institute Australia (MIA) for an Australian-first live-streamed symposium to support multidisciplinary clinicians in navigating the evolving treatment landscape.

Chaired by Professor Georgina Long AO and featuring world-leading multidisciplinary experts, this symposium will provide you with practical, case-based insights into patient and treatment selection, multidisciplinary coordination and response assessment — equipping clinicians to deliver this new standard of care — and will highlight upcoming research efforts to further improve outcomes for patients.

For more information, click here.